Ticker
APRECompany Name
APREA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Net Income Common Stock | Return on Assets |
---|---|---|---|
6/30/2025 | $ 17.31M | $ -13.85M | -80.01% |
3/31/2025 | $ 20.22M | $ -14.08M | -69.63% |
12/31/2024 | $ 23.98M | $ -12.96M | -54.04% |
9/30/2024 | $ 26.89M | $ -13.51M | -50.22% |
6/30/2024 | $ 29.96M | $ -12.93M | -43.14% |
3/31/2024 | $ 33.2M | $ -12.72M | -38.3% |
12/31/2023 | $ 22.65M | $ -14.29M | -63.08% |
9/30/2023 | $ 25.77M | $ -13.29M | -51.56% |
6/30/2023 | $ 28.68M | $ -14.11M | -49.18% |
3/31/2023 | $ 32.02M | $ -109.11M | -340.74% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Assets
(=) ROA
ROA for APREA THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -51.16M ] / Assets [ $ 102.83M ]
(=) ROA [ -49.75% ]
Minimum
Dec 31, 2022
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.44K |
---|---|
min | -33.4% |
max | 33.98% |
average | 0.12% |
median | 1.53% |
std | 10.61% |